Zevra Therapeutics is trading at $10.74, up 8.09% after hours, and the reason for the move remains unclear.
- No company-specific announcement dated October 16 explaining the rise was found; Zevra’s investor-relations release list shows its latest release was September 2.
- Broader markets were sharply lower on October 16, but available evidence does not establish that market-wide sentiment caused the opposite-direction after-hours move.